G-Protein Coupled Receptors (GPCRs) Market: Advancements in Physiology to Drive Market Demand

G-protein-coupled receptors (GPCRs) are widely regarded as the most diverse and largest group of membrane receptors in organisms called eukaryotes. These receptors play the role of an inbox for messages that come in the form of proteins, sugars, lipids, peptides, and light energy. These messages tell the cells about the absence or presence of life-sustaining nutrients and lights in their surroundings. These cells also convey the information that is sent by various other cells. The global g-protein coupled receptors (GPCRS) market gathers momentum from growing prevalence of various lifestyle diseases such as diabetes.

G-protein-coupled receptors play an important role in an extremely wide array of functions in the body of a human being. The augmented understanding about these receptors has played a significant role in the modern day medicine, which is estimated to drive the development of the global g-protein coupled receptors (GPCRS) market in years to come. As a matter of fact, an estimations by researchers say that between one-third and one-half of all the drugs that are marketed act through its binding with G-protein-coupled receptors.

Request Brochure of Reporthttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=550

High Prevalence of Lifestyle Diseases Drive Growth of the Market

A substantial rise in the incidences of various lifestyle-related disorders such as respiratory issues, cardiovascular infections, and breast cancer is driving the augmented need for the development of better and novel treatment methods. G-protein coupled receptors have proven to be highly useful in the innovative work for invention of newer substances of medication. In addition, augmented funding by governments is likely to act in favor the growth of the global g-protein coupled receptors (GPCRS) market over the tenure of assessment. Governments are increasingly funding in research on subjects like high-throughput screening methods, sedate targets, orphan drug receptors, and biosensors.

Utilization of G-protein-coupled receptors assays in cancer research produces substantial amount of revenue. Numerous research projects have proved that the G-protein-coupled receptors activity exhibits the following conditions in cancer patients

  • drug resistance
  • angiogenesis
  • tumor proliferation
  • metastasis
  • invasiveness

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=550

North America is likely to come up as one of the promising regions in the global g-protein coupled receptors (GPCRS) market over the a in the field of cancer research.

This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.

The global GPCRs market has been segmented based on of assay type, therapeutic area, and geography. Based on assay type, the GPCRs market has been categorized into six major segments: cAMP assays, calcium level detection assays, GTPγS binding assays, reporter gene assays, receptor internalization assays, and cGMP assays. The market for these segments has been extensively analyzed based on of their effectiveness, usefulness, sales, and geographic presence. Market revenue in terms of USD million for the period between 2012 and 2024 along with the compound annual growth rate (CAGR %) from 2014 to 2024 are provided for all the segments, considering 2013 as the base year.

In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary, orthopedics, etc.). Market revenue in terms of USD million for the period between 2012 and 2024 along with the compound annual growth rate (CAGR %) from 2014 to 2024 are provided for all the segments, considering 2013 as the base year.

Request for Discount – https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=550

The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that have strong impact on the GPCRs market currently and could influence the market in future as well. The market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter’s Five Forces analysis is also explained in this section to understand the GPCRs market considering different parameters that have an impact on the sustainability of the companies operating in the GPCRs market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Major geographic regions have been further divided into major national markets, viz. North America (the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), and Asia Pacific (China, Japan, India, and Rest of Asia Pacific). Moreover, Rest of the World has been further subdivided into three regions: Latin America, the Middle East, and Africa. Market revenue in terms of USD million for the period between 2012 and 2024 along with the CAGR % from 2014 to 2024 are provided for all the regional and national markets considering 2013 as the base year.

Buy G-Protein Coupled Receptors (GPCRs) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=550&ltype=S

The recommendations section included in the report would assist existing market players in expanding their market shares and new companies in establishing their presence in the global market. The report also profiles major players in the GPCRs market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation, Abcam plc, and HD Biosciences Co. Ltd.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/